T2 Biosystems Inc (TTOO) reports a 34% revenue increase, driven by sepsis test sales and a pivotal partnership with Cardinal Health, despite ongoing financial challenges.
LEXINGTON, Mass. AP) — T2 Biosystems Inc. TTOO) on Thursday reported a loss of $10.1 million in its third quarter.